Table 1. Clinical data of 376 patients with hepatocellular carcinoma (HCC) from the cancer genome atlas (TCGA) cohort in this research.
| Level | Overall |
| N | 376 |
| Age (median [IQR]) | 61.00 [51.00, 69.00] |
| Gender (%) | |
| female | 122 (32.4) |
| male | 254 (67.6) |
| Status (%) | |
| Alive | 243 (64.6) |
| Dead | 132 (35.1) |
| Not Reported | 1 (0.3) |
| pathologic_T (%) | |
| T1 | 185 (49.5) |
| T2 | 94 (25.1) |
| T3 | 81 (21.7) |
| T4 | 13 (3.5) |
| TX | 1 (0.3) |
| pathologic_N (%) | |
| N0 | 257 (68.5) |
| N1 | 4 (1.1) |
| NX | 114 (30.4) |
| pathologic_M (%) | |
| M0 | 272 (72.3) |
| M1 | 4 (1.1) |
| MX | 100 (26.6) |
| pathologic_stage (%) | |
| Stage I | 175 (49.7) |
| Stage II | 86 (24.4) |
| Stage III | 86 (24.4) |
| Stage IV | 5 (1.4) |
| tumor_stage (%) | |
| stage i | 175 (46.5) |
| stage ii | 86 (22.9) |
| stage iii | 86 (22.9) |
| stage iv | 5 (1.3) |
| Unknown | 24 (6.4) |